BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 418581)

  • 1. [Lead concentration in blood during treatment with coumarin derivatives].
    Fischer H; Wehran HI
    Z Arztl Fortbild (Jena); 1978 Mar; 72(5):211. PubMed ID: 418581
    [No Abstract]   [Full Text] [Related]  

  • 2. Transient acquired resistance to the coumarin anticoagulants phenprocoumon and acenocoumarol.
    de Wolff FA; ten Cate JW
    Scand J Haematol; 1979 Nov; 23(5):437-41. PubMed ID: 542805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of naproxen on the thrombocyte bleeding time and on the anticoagulant treatment with phenprocoumon].
    Angelkort B
    Fortschr Med; 1978 Jun; 96(23):1249-52. PubMed ID: 658877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of fibrinopeptide A in patients treated with phenprocoumon.
    Harenberg J; Haas R; Zimmermann R
    Thromb Haemost; 1981 Jun; 45(3):282-4. PubMed ID: 7281107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the interaction between the anti-inflammatory substance proquazone (RU 43-715) and phenprocoumone.
    Vinazzer H
    Int J Clin Pharmacol Biopharm; 1977 May; 15(5):214-6. PubMed ID: 326688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elevated lead concentration in the blood during treatment with coumarin derivatives].
    Loll H
    Med Lab (Stuttg); 1975 Aug; 28(8):177-9. PubMed ID: 1186591
    [No Abstract]   [Full Text] [Related]  

  • 7. [Falithrom and pregnancy].
    Bredow V; Pietsch P
    Zentralbl Gynakol; 1985; 107(2):106-9. PubMed ID: 3873150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of daily administration of naproxen on the prothrombin complex activity in patients under long-term therapy with phenprocoumon.
    Petersen PB; Husted S; Mortensen A; Andreasen F
    Scand J Rheumatol; 1979; 8(1):54-6. PubMed ID: 311940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin and phenprocoumon].
    Deutsch E
    Dtsch Med Wochenschr; 1978 Mar; 103(12):496. PubMed ID: 639670
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of allopurinol with phenprocoumon in man.
    Jähnchen E; Meinertz I; Gilfrich HJ
    Klin Wochenschr; 1977 Aug; 55(15):759-61. PubMed ID: 895010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjustment of phenprocoumon dosage utilizing a pharmacokinetic model.
    Böhm K; Vogel G; Barthel W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):141-6. PubMed ID: 2459009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spontaneous intramural hemorrhage within the intestinal wall during anticoagulation].
    Müller C; Claudi B
    Helv Chir Acta; 1976 Dec; 43(5-6):579-85. PubMed ID: 1087301
    [No Abstract]   [Full Text] [Related]  

  • 13. [Migraine and marcumar].
    Behnen HJ
    Dtsch Med Wochenschr; 1979 Jan; 104(1):32-3. PubMed ID: 759135
    [No Abstract]   [Full Text] [Related]  

  • 14. [Secondary resistance to coumarin derivatives in a patient with a hypercoagulability syndrome].
    Marburger C; Maclachian D; Haisken O; deVries JX; Walter-Sack I; Andrassy K; Nawroth P; Ziegler R; Kather H
    Dtsch Med Wochenschr; 1997 Aug; 122(31-32):959-64. PubMed ID: 9280715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of lung tumour colony reduction caused by coumarin anticoagulation.
    Hilgard P; Maat B
    Eur J Cancer (1965); 1979 Feb; 15(2):183-7. PubMed ID: 436894
    [No Abstract]   [Full Text] [Related]  

  • 16. [Increased effect of phenprocoumon (Marcumar) in nephrotic syndrome].
    Heni N; Völger R; Glogner P
    MMW Munch Med Wochenschr; 1980 Feb; 122(5):175-6. PubMed ID: 6767946
    [No Abstract]   [Full Text] [Related]  

  • 17. [Course control of platelet function and blood lipid levels during a 2 years prospective study on the prevention of reinfarction with acetylsalicylic acid, phenprocoumon and placebo].
    Walter E; Weber E; Loew D
    Verh Dtsch Ges Inn Med; 1978; (84):1481-5. PubMed ID: 369187
    [No Abstract]   [Full Text] [Related]  

  • 18. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
    Breddin K; Loew D; Lechner K; Oberla K; Walter E
    Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The concomitant use of suloctidil and a long-acting oral anticoagulant.
    Verhaeghe R; Vanhoof A
    Acta Clin Belg; 1977; 32(1):36-8. PubMed ID: 331824
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.
    Breddin K; Loew D; Lechner K; Uberla K; Walter E
    Thromb Haemost; 1979 Feb; 41(1):225-36. PubMed ID: 483232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.